Company / CapEx per Share
BioNexus Gene Lab Corp CapEx per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.02
FY2025
5-year range
$0.00 / $0.02
FY2021-FY2025
Trend
+60.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share has increased for 3 consecutive years, from $0.00 in FY2022 to $0.02 in FY2025.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of +38.0%.
Improved from $0.01 to $0.02 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +38.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capex per share increased 60.2% year-over-year.
- Lowest capex per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | +60.2% |
| FY2024 | $0.01 | +24.5% |
| FY2023 | $0.01 | - |
| FY2022 | $0.00 | -100.0% |
| FY2021 | $0.00 | -99.6% |
| FY2020 | $0.00 | +2289.6% |
| FY2019 | $0.00 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026